Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1951 2
1953 1
1957 3
1958 1
1961 2
1962 1
1963 5
1964 5
1965 2
1966 1
1967 1
1969 1
1971 1
1972 2
1973 1
1974 1
1979 1
1980 1
1981 1
1982 3
1983 2
1984 5
1985 5
1986 10
1987 13
1988 9
1989 9
1990 12
1991 9
1992 20
1993 20
1994 15
1995 20
1996 21
1997 21
1998 26
1999 31
2000 35
2001 37
2002 37
2003 65
2004 77
2005 102
2006 122
2007 121
2008 160
2009 177
2010 198
2011 280
2012 288
2013 338
2014 398
2015 432
2016 520
2017 552
2018 591
2019 659
2020 798
2021 904
2022 1001
2023 978
2024 1123
2025 1345
2026 464

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,785 results

Results by year

Filters applied: . Clear all
Page 1
Acute pancreatitis: mechanisms and therapeutic approaches.
Hu Q, Hu Y, Tan C, Yang Y, Su H, Huang Z, Tang W, Wang R, Liu J, Wan M. Hu Q, et al. Among authors: su h. Signal Transduct Target Ther. 2026 Jan 14;11(1):15. doi: 10.1038/s41392-025-02394-6. Signal Transduct Target Ther. 2026. PMID: 41530118 Free PMC article. Review.
Multiomic integration reveals tumoral heterogeneity of lipid dependence within lethal group 3 medulloblastoma.
Bernardi F, Torrejon J, Basili I, Van Ommeren R, Marsaud V, Yu H, Talbot J, Souphron J, Indersie E, Forget A, Bonneau B, Massiot A, Alcazar C, Figeac L, Bonerandi E, Cancila G, Sirbu O, Yadav N, Mohanakrishnan D, Lombard B, Loew D, Poullet P, Liva S, Lovino M, Lin IH, Nakashima T, Gharsalli T, Nicolas PA, Yubuki N, Ribas RA, Colsch B, Chu-Van E, Castelli F, Sampaio JL, Leboucher S, Lasgi C, Besse L, Soler MN, Lo Re V, Planque N, Abeysundara N, Balin P, Wang H, Su H, Wu X, Cavalli FMG, Saulnier O, Ficarra E, Di Marcotullio L, Kumegawa K, Maruyama R, Kawauchi D, Picard D, Remke M, Riffaud L, Puiseux C, Bouchoucha Y, Huybrechts S, Simbozel M, Bourdeaut F, Varlet P, Puget S, Blauwblomme T, Andrianteranagna M, Planchon JM, Dugourd A, Saez-Rodriguez J, Barillot E, Servant N, Martignetti L, Rich J, Kool M, Pfister SM, Agnihotri S, Suzuki H, Fanjul M, Wang WJ, Tsai JW, Sun RC, Beccaria K, Dufour C, Sarry JE, Michealraj KA, Taylor MD, Ayrault O. Bernardi F, et al. Among authors: su h. Cancer Cell. 2026 Feb 9;44(2):383-404.e18. doi: 10.1016/j.ccell.2025.12.012. Epub 2026 Jan 15. Cancer Cell. 2026. PMID: 41544627
Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee.
Poli MC, Aksentijevich I, Bousfiha AA, Cunningham-Rundles C, Hambleton S, Klein C, Morio T, Picard C, Puel A, Rezaei N, Seppänen MRJ, Somech R, Su HC, Sullivan KE, Torgerson TR, Meyts I, Tangye SG. Poli MC, et al. Among authors: su hc. J Hum Immun. 2025 Apr 15;1(1):e20250003. doi: 10.70962/jhi.20250003. eCollection 2025 May 5. J Hum Immun. 2025. PMID: 41608114 Free PMC article.
The seven enigmas of SARS-CoV-2: from the past to the future.
Andreakos E, Arkin L, Bastard P, Bolze A, Borghesi A, Brodin P, Casanova JL, Casari G, Cobat A, Drolet B, Fellay J, Hsieh E, Meyts I, Mogensen TH, Sancho-Shimizu V, Spaan AN, Su HC, Vinh DC, Yatim A, Zhang Q, Zhang SY; COVID Human Genetic Effort+. Andreakos E, et al. Among authors: su hc. J Hum Immun. 2025 Nov 3;1(4):e20250149. doi: 10.70962/jhi.20250149. Epub 2025 Oct 24. J Hum Immun. 2025. PMID: 41347066 Free PMC article.
Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial.
Yin Y, Zhang Q, Sun T, Hao C, Wang Z, Yang J, Wang Y, Shi Y, Sun J, Ouyang Q, Su H, Wu J, Gan L, Han M, Gao L, Wang X, Zhao B, Li H, Zhao J, Yang H, Ning F, Tian F, Zhang J, Sun H, Niu Z, Zong H, Zang A, Wang X, Qian X, Wu S, Nie J, He L, Cheng Y, Hao Y, Zhai Y, Li H, Wang J, Wei S, Li M, Liu Y, Guo H, Hu Q, Liu L, Han X, Luo R, Ni M, Tang X, Zhai Z, Ding M, Wang H, Shen P, Wang X, Liu L, Chen W, Liu G, Cai Z, Jiang Z. Yin Y, et al. Among authors: su h. Signal Transduct Target Ther. 2025 Dec 18;10(1):414. doi: 10.1038/s41392-025-02475-6. Signal Transduct Target Ther. 2025. PMID: 41413016 Free PMC article. Clinical Trial.
Mapping the Global Distribution of Babesia Infections.
Fu BK, Tang T, Yue M, Chen JJ, Su H, Huang XB, Yang YF, Hay SI, Fang LQ, Liu W. Fu BK, et al. Among authors: su h. Transbound Emerg Dis. 2025 Nov 24;2025:5889219. doi: 10.1155/tbed/5889219. eCollection 2025. Transbound Emerg Dis. 2025. PMID: 41333613 Free PMC article.
10,785 results
You have reached the last available page of results. Please see the User Guide for more information.